Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 2006

View Archived Issues

Sustained quality of life gains seen with rotigotine in restless legs syndrome

Investigational anticonvulsant increases high-voltage sleep

Series B financing to support preclinical efforts at GlycoMimetics

Phase III breast cancer study of tesmilifene cleared to continue

Nilotinib safe in imatinib-resistant leukemia patients in phase I study

Epoetin delta evaluated in patients with chronic kidney disease

Cloretazine active in elderly acute myeloid leukemia patients

Studies of NRP-104 pharmacokinetics, abuse potential reported

YM-393059: a novel dual inhibitor of PDE7A and PDE4 for inflammatory disorders

At 5 years, papillomavirus vaccine Gardasil found to induce immune memory

Phase III program for Gabitril in GAD fails to meet endpoints

PMA filed for OP-1 Putty in posterolateral lumbar spine fusion surgeries

Series B financing at Tengion

Wythe and VeroScience sign agreement for Cycloset

ATLAS trial results show adalimumab effects in ankylosing spondylitis

MK-0812 not effective in rheumatoid arthritis

Efficacy of certolizumab pegol independent of C-reactive protein in Crohn's disease

Pfizer patents novel nicotinic acetylcholine receptor modulators for promoting smoking cessation

Recent patents report new therapeutic agents for metabolic disorders

Recent patents report new anticoagulants for thrombotic disorders

Nastech and Amylin sign development agreement for exenatide nasal spray

Metabolex and Ortho-McNeil enter metabolic disease strategic agreement

Schering AG terminates Alprox-TD license with NexMed

Affymax and Takeda sign agreement for Hematide

Valera seeks to begin clinical studies of VP-004 naltrexone implant

End of phase II meeting for Anturol

CF-102 begins nonclinical development

Macugen studied in phase IV maintenance trial

Celacade shows efficacy in NYHA Class II chronic heart failure patients

European approval for Tysabri in MS

Sprycel approved for two new indications

Approvable letter for Lybrel oral contraceptive

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...